• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

For Industry

  • Print
  • Share
  • E-mail

Patient-Focused Drug Development: Disease Area Meetings Planned for Fiscal Years 2013-2015

Note: Unless otherwise noted, this schedule is subject to change. Meeting information for each disease area will be posted as it becomes available. More information on the selection of disease areas for Patient-Focused Drug Development can be found in the Federal Register Notice (PDF - 111KB) published on April 11, 2013.

Meetings Planned for FY 2014 and FY 2015

  • Sickle cell disease:  February 7, 2014
  • Fibromyalgia: March 26, 2014

  • Pulmonary Arterial Hypertension: May 13, 2014

  • Neurological manifestations of inborn errors of metabolism: June 10, 2014  
  • Alpha-1 antitrypsin deficiency

  • Breast cancer

  • Chronic Chagas disease

  • Female sexual dysfunction

  • Hemophilia A, Hemophilia B, von Willebrand disease, and other heritable bleeding disorders
  • Idiopathic pulmonary fibrosis

  • Irritable bowel syndrome, gastroparesis, and gastroesophageal reflux disease with persistent regurgitation symptoms on proton-pump inhibitors

  • Neurological manifestations of inborn errors of metabolism

  • Parkinson’s disease and Huntington’s disease

 


 

Meetings Held in FY 2013